These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36193331)
1. Mendelian Susceptibility to Mycobacterial Diseases (MSMD) in a 13-Year-Old Ethiopian Girl with Autosomal Dominant Interferon Gamma Receptor 1(IFN- Gebeyehu NA; Deribessa SJ; Alexandra F; Demissie MT; Mihretu Gebre W; Gebremariam AM; Engliz DM; Kidane TY; Million Bekele L; Weldetsadik AY Case Rep Infect Dis; 2022; 2022():6534009. PubMed ID: 36193331 [TBL] [Abstract][Full Text] [Related]
2. Mendelian susceptibility to mycobacterial diseases: State of the puzzle. Errami A; Bousfiha AA Qatar Med J; 2023; 2023(2):25. PubMed ID: 38025345 [TBL] [Abstract][Full Text] [Related]
3. Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases. Ono R; Tsumura M; Shima S; Matsuda Y; Gotoh K; Miyata Y; Yoto Y; Tomomasa D; Utsumi T; Ohnishi H; Kato Z; Ishiwada N; Ishikawa A; Wada T; Uhara H; Nishikomori R; Hasegawa D; Okada S; Kanegane H J Clin Immunol; 2023 Feb; 43(2):466-478. PubMed ID: 36336768 [TBL] [Abstract][Full Text] [Related]
4. Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity. Dolezalova K; Strachan T; Matej R; Ricna D; Bloomfield M Eur J Dermatol; 2022 Sep; 32(4):495-504. PubMed ID: 36069176 [TBL] [Abstract][Full Text] [Related]
5. Fibrosing mediastinitis in a child with Mendelian susceptibility to mycobacterial disease possibly due to Bacillus Calmette-Guérin. Sharifinejad N; Mahdaviani SA; Fallah S; Fard NK; Norouzi A; Jamee M; Sadeghi-Shabestari M; Marjani M; Malekshoar M; Farnia P; Velayati AA Allergy Asthma Clin Immunol; 2022 Nov; 18(1):96. PubMed ID: 36397171 [TBL] [Abstract][Full Text] [Related]
6. Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease. Nekooie-Marnany N; Deswarte C; Ostadi V; Bagherpour B; Taleby E; Ganjalikhani-Hakemi M; Le Voyer T; Rahimi H; Rosain J; Pourmoghadas Z; Sheikhbahaei S; Khoshnevisan R; Petersheim D; Kotlarz D; Klein C; Boisson-Dupuis S; Casanova JL; Bustamante J; Sherkat R J Clin Immunol; 2018 Oct; 38(7):787-793. PubMed ID: 30255293 [TBL] [Abstract][Full Text] [Related]
7. Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency. Rosain J; Kiykim A; Michev A; Kendir-Demirkol Y; Rinchai D; Peel JN; Li H; Ocak S; Ozdemir PG; Le Voyer T; Philippot Q; Khan T; Neehus AL; Migaud M; Soudée C; Boisson-Dupuis S; Marr N; Borghesi A; Casanova JL; Bustamante J J Clin Immunol; 2024 Feb; 44(3):62. PubMed ID: 38363432 [TBL] [Abstract][Full Text] [Related]
8. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Bustamante J; Boisson-Dupuis S; Abel L; Casanova JL Semin Immunol; 2014 Dec; 26(6):454-70. PubMed ID: 25453225 [TBL] [Abstract][Full Text] [Related]
9. Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease. Sarrafzadeh SA; Nourizadeh M; Mahloojirad M; Fazlollahi MR; Shokouhi Shoormasti R; Badalzadeh M; Deswarte C; Casanova JL; Pourpak Z; Bustamante J; Moin M J Clin Immunol; 2019 Apr; 39(3):287-297. PubMed ID: 30715640 [TBL] [Abstract][Full Text] [Related]
10. A Syrian Refugee in Iraq Diagnosed as a Case of IL12RB1 Deficiency in Japan Using Dried Blood Spots. Al-Kzayer LFY; Yassin AK; Salih KH; Shigemura T; Sano K; Al-Simaani RBY; Tanaka M; Nakazawa Y; Okuno Y Front Immunol; 2019; 10():58. PubMed ID: 30740107 [TBL] [Abstract][Full Text] [Related]
11. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India. Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM Front Immunol; 2021; 12():631298. PubMed ID: 33732252 [TBL] [Abstract][Full Text] [Related]
12. Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review. Khavandegar A; Mahdaviani SA; Zaki-Dizaji M; Khalili-Moghaddam F; Ansari S; Alijani S; Taherzadeh-Ghahfarrokhi N; Mansouri D; Casanova JL; Bustamante J; Jamee M J Allergy Clin Immunol; 2024 May; 153(5):1432-1444. PubMed ID: 38341181 [TBL] [Abstract][Full Text] [Related]
13. [Mendelian susceptibility to mycobacterial disease: a case report of disseminated infection due to Mycobacterium avium]. Darleguy A; Bost-Bru C; Pagnier A; Plantaz D; Piolat C; Nugues F; Picard C Arch Pediatr; 2013 Jul; 20(7):758-61. PubMed ID: 23726680 [TBL] [Abstract][Full Text] [Related]
14. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients. Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053 [TBL] [Abstract][Full Text] [Related]
15. Autosomal Recessive IL-12p40 Deficiency due to a Mutation in the Melo KM; Tavares FS; Antunes TS; Condino-Neto A; Silva Segundo GR; Macedo ACT; Ferreira AP; Valente CFC Pediatr Allergy Immunol Pulmonol; 2024 Mar; 37(1):33-36. PubMed ID: 38484269 [No Abstract] [Full Text] [Related]
16. Adult-onset Mendelian Susceptibility to Mycobacterial Diseases: A case report and systematic literature review. Yang Y; Xia L; Lu S Heliyon; 2023 Dec; 9(12):e22632. PubMed ID: 38058431 [TBL] [Abstract][Full Text] [Related]
17. Impact of molecular diagnosis on treating Mendelian susceptibility to mycobacterial diseases. Wang LH; Yen CL; Chang TC; Liu CC; Shieh CC J Microbiol Immunol Infect; 2012 Dec; 45(6):411-7. PubMed ID: 23036270 [TBL] [Abstract][Full Text] [Related]
18. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease. Esteve-Solé A; Sologuren I; Martínez-Saavedra MT; Deyà-Martínez À; Oleaga-Quintas C; Martinez-Barricarte R; Martin-Nalda A; Juan M; Casanova JL; Rodriguez-Gallego C; Alsina L; Bustamante J Crit Rev Clin Lab Sci; 2018 May; 55(3):184-204. PubMed ID: 29502462 [TBL] [Abstract][Full Text] [Related]
19. Bacillus Calmette-Guérin (BCG)-associated hemophagocytic lymphohistiocytosis in the setting of IFN-γR1 deficiency: A diagnostic dilemma. Razaghian A; Parvaneh L; Delkhah M; Abbasi A; Sadeghirad P; Shahrooei M; Parvaneh N EJHaem; 2020 Jul; 1(1):334-337. PubMed ID: 35847695 [TBL] [Abstract][Full Text] [Related]
20. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs). Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]